Carbon dioxide and nitrogen management and valorisation
The expected outcome are lab-scale validated new biological, chemical, physical routes that integrate the capture and/or recovery of CO2 and N species, storage and their conversion into value-added products, and/or net zero commodities, chemicals, fuels and energy vectors. The innovative technologies, sustained by renewable energy, avoiding the use of critical raw materials and adopting the life cycle and circular thinking driven approach, will enable CO2 and N management and valorisation and in turn reduce greenhouse gas (GHG) emissions, as well as nitrogen and carbon losses.
Mid- to long-term and systems integrated energy storage
The expected outcome are lab-scale validated technologies for mid-long term storage (from days to months) able to increase energy systems flexibility, sectors coupling, demand response and smart interoperability solutions, while avoiding the use of critical raw materials and adopting the life cycle and circular thinking driven approach. The innovative technologies will enable to host higher penetration of intermittent renewable technologies both in centralised or decentralised systems from large to mid-scale size.
For projects to address existing gaps in the diagnosis and treatment of cardiovascular diseases (CVD), which would pave the way for early and more accurate diagnosis, as well as, first in class therapies for major CVD conditions including haemorrhagic and ischemic stroke, aneurysm, cardiomyopathy and certain types of arrhythmias and other conditions, for which no effective treatments are currently available. Advanced genetic testing taking into account complex inheritance, or combining genetic testing, transcriptomics, proteomics and metabolomics analysis with clinical phenotype can improve clinical management of the CVD and identify more accurately, who is likely to be at risk for major cardiovascular events such as heart failure or sudden death, and thus will have a substantive impact on the practice of cardiology.
Towards the healthcare continuum: technologies to support a radical shift from episodic to continuous healthcare
For projects to develop systems and technologies starting at very low technology readiness level (TRL) for unobtrusive monitoring of human health with new continuous and personal imaging and sensing modalities, implementing continuous assessment, processing and analysis of the data to identify early signs of disease. This call can support innovative technologies ranging from the sensor level up to the system level for effective integration of multimodal data.
DNA-based digital data storage
For projects to explore scalable and reliable high-throughput approaches for using DNA as a general data-storage medium. Solutions would thus need to address the read/write/edit operations of digital data in synthetic DNA, capturing the expected advantages of high density and stability and longevity of this form of data storage. Proposed techniques should deliver qualitative advances in key parameters such as throughput, DNA-length (well above a few hundred mers), reliability (coupling efficiency), speed and cost. Beyond the usual storage applications, there is also scope for radically different scenarios for such a technology, for instance for data-processing, in-vivo sensing or fingerprinting.
Alternative approaches to quantum information processing, communication, and sensing
For projects to develop innovative approaches to encoding, manipulating, or storing information in quantum objects, or to exploiting quantum phenomena for information processing, communication, and sensing in a way that differs from the mainstream approaches currently being pursued in quantum research. Proposals should clearly identify the limits of the current quantum information processing paradigms they are trying to improve upon and propose relevant metrics to track progress and demonstrate success or a superior paradigm compared with conventional quantum information processing approaches.